Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/43149
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHon K.L.-
dc.contributor.authorLeung K.K.Y.-
dc.contributor.authorOberender F.-
dc.contributor.authorLeung A.K.C.-
dc.date.accessioned2021-09-03T01:13:07Z-
dc.date.available2021-09-03T01:13:07Z-
dc.date.copyright2021-
dc.date.created20210702-
dc.date.issued2021-07-02en
dc.identifier.citationDrugs in Context. 10 (no pagination), 2021. Date of Publication: 2021.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/43149-
dc.description.abstractBackground: Septic shock is a common critical illness associated with high morbidity and mortality in children. This article provides an updated narrative review on the management of septic shock in paediatric practice. Method(s): A PubMed search was performed using the following Medical Subject Headings: "sepsis", "septic shock" and "systemic inflammatory response syndrome". The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies and reviews. The search was limited to the English literature and specific to children. Result(s): Septic shock is associated with high mortality and morbidity. The outcome can be improved if the diagnosis is made promptly and treatment initiated without delay. Early treatment with antimicrobial therapy, fluid therapy and vasoactive medications, and rapid recognition of the source of sepsis and control are the key recommendations from paediatric sepsis management guidelines. Conclusion(s): Most of the current paediatric sepsis guideline recommendations are based on the adult population; therefore, the research gaps in paediatric sepsis management should be addressed.Copyright © 2021 Hon KL, Leung KKY, Oberender F, Leung AKC.-
dc.publisherBioexcel Publishing LTD-
dc.relation.ispartofDrugs in Context-
dc.subject.meshantimicrobial therapy-
dc.subject.meshblood purification-
dc.subject.meshclinical feature-
dc.subject.meshclinical outcome-
dc.subject.meshdifferential diagnosis-
dc.subject.meshdisease association-
dc.subject.meshearly intervention-
dc.subject.meshextracorporeal oxygenation-
dc.subject.meshfluid resuscitation-
dc.subject.meshfluid therapy-
dc.subject.meshinfection control-
dc.subject.meshintensive care-
dc.subject.meshlaboratory test-
dc.subject.meshmorbidity-
dc.subject.meshmortality-
dc.subject.meshnutrition-
dc.subject.meshpathophysiology-
dc.subject.mesh*patient care-
dc.subject.meshpatient monitoring-
dc.subject.meshpediatric intensive care unit-
dc.subject.mesh*pediatrics-
dc.subject.meshpractice guideline-
dc.subject.meshprognosis-
dc.subject.meshrenal replacement therapy-
dc.subject.mesh*septic shock/di [Diagnosis]-
dc.subject.mesh*septic shock/dt [Drug Therapy]-
dc.subject.mesh*septic shock/ep [Epidemiology]-
dc.subject.mesh*septic shock/et [Etiology]-
dc.subject.mesh*septic shock/pc [Prevention]-
dc.subject.mesh*septic shock/su [Surgery]-
dc.subject.mesh*septic shock/th [Therapy]-
dc.subject.meshstress ulcer-
dc.subject.meshsurgical technique-
dc.subject.meshsystemic inflammatory response syndrome-
dc.subject.meshtherapy delay-
dc.subject.meshantiinfective agent/dt [Drug Therapy]-
dc.subject.meshantiinfective agent/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshcorticosteroid/dt [Drug Therapy]-
dc.subject.meshcorticosteroid/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshhypertensive factor/dt [Drug Therapy]-
dc.subject.meshhypertensive factor/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshimmunoglobulin/dt [Drug Therapy]-
dc.subject.meshimmunoglobulin/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshinotropic agent/dt [Drug Therapy]-
dc.subject.meshinotropic agent/pv [Special Situation for Pharmacovigilance]-
dc.subject.meshvasoactive agent/dt [Drug Therapy]-
dc.subject.meshvasoactive agent/pv [Special Situation for Pharmacovigilance]-
dc.titlePaediatrics: How to manage septic shock.-
dc.typeReview-
dc.type.studyortrialReview article (e.g. literature review, narrative review)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.7573/DIC.2021-1-5-
dc.publisher.placeUnited Kingdom-
dc.identifier.institution(Hon, Leung) Paediatric Intensive Care Unit, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong-
dc.identifier.institution(Oberender) Paediatric Intensive Care Unit, Monash Children's Hospital, Melbourne, Australia-
dc.identifier.institution(Oberender) Monash University, School of Clinical Sciences, Department of Paediatrics, Melbourne, Australia-
dc.identifier.institution(Leung) Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada-
dc.subect.keywordshuman-
dc.subect.keywordsreview-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeReview-
item.cerifentitytypePublications-
item.grantfulltextnone-
Appears in Collections:Articles
Show simple item record

Page view(s)

84
checked on Apr 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.